You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A novel magnetic resonance detector for early diagnosis of bladder cancer recurre
SBC: ABQMR, INC. Topic: N/ADESCRIPTION (provided by applicant): Bladder cancer is a common and costly disease. More than 60,000 new cases of bladder cancer are diagnosed each year in the U.S. It is the fourth most common cancer among men and the 10th among women, with a prevalence of about 500,000 in the US. Our compact NMR device will provide a rapid, accurate differential diagnosis of bladder cancer by detecting the tumor ...
SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health -
Pediatric Acceptable Formulation of Amiodarone
SBC: ACADEMIC PHARMACEUTICALS Topic: N/ADESCRIPTION (provided by applicant): IV amiodarone is the first line therapy for life threatening ventricular as well as supraventricular arrhythmias. However, the Tween 80 and benzyl alcohol diluents limits the rate of administration severely, due to hypotension and myocardial contractile depression. These adverse toxicities contribute to the high mortality of cardiac arrest patients who have ma ...
SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health -
Controlled Release Vascular Grafts
SBC: VesselTek Biomedical LLC Topic: N/ADESCRIPTION (provided by applicant): In the United States, it is estimated that 8 million people suffer from peripheral artery disease (PAD). PAD is characterized by a gradual reduction in blood flow to the muscular arteries of the lower extremities caused by atherosclerosis. For those with severe PAD, lower extremity bypass grafting remains the predominant option for limb salvage. Although native ...
SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health -
SECONDARY PREVENTION OF ALCOHOLISM VIA COMPUTER SOFTWARE
SBC: Alcohol Self-control Program Topic: N/AN/A
SBIR Phase I 1990 Department of Health and Human Services -
"Rolling Deflectometer"
SBC: Applied Research Associates, Inc. Topic: N/AN/A
SBIR Phase II 1996 Department of Transportation -
Semiautomatic, Quantitative Analysis of Funds
SBC: APPLIED SCIENCES LABORATORY, INC. Topic: N/AN/A
SBIR Phase II 1996 Department of Health and Human Services -
Non-invasive Assessment of Insulin Resistance
SBC: BIOCHEMANALYSIS CORPORATION Topic: N/ADESCRIPTION (provided by applicant): The overall objective of this grant is to develop a non-invasive method for assessment of insulin resistance and impaired glucose tolerance (IGT) as a measure of pre-diabetes suitable for application to large-scale screening studies and to individualized preventive strategies in patients at risk for development of diabetes. This new approach is based on the kno ...
SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health -
MULTIDIRECTIONAL ULTRASONIC BLOOD-FLOW-IMAGING SYSTEM
SBC: BIO-IMAGING RESEARCH, INC. Topic: N/AN/A
SBIR Phase I 1990 Department of Health and Human Services -
MICROHOLOGRAPHIC DIAGNOSIS OF CERVICAL NEOPLASIA
SBC: BIO-LOGIC SYSTEMS CORPORATION Topic: N/ATHIS RESEARCH WILL DEVELOP A MICROHOLOGRAPHIC TECHNIQUE FOR THE DIAGNOSIS OF CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN). THE DESIGN OF THE INSTRUMENT WILL ALLOW FOR THE RECORDING OF THE FEMALE GENITAL TRACT, IN PARTICULAR THE CERVIX, WHICH CAN BE SUBSEQUENTLY EXAMINED UNDER A MICROSCOPE WITH RESOLUTION COMPARABLE TO THAT OBTAINED IN PATHOLOGICAL AND HISTOLOGICAL EXAMINATIONS. THE METHOD UTILIZES CON ...
SBIR Phase I 1990 Department of Health and Human Services -
XRpro Discovery of Decorporation Agents
SBC: Icagen, Inc. Topic: N/ADESCRIPTION (provided by applicant): Caldera Pharmaceuticals will use award-winning XRpro, a high throughput, label-free technology for producing nano-engineered radionuclide decorporation agents that are highly specific for their target radionuclide over similar elements. This proposal displays preliminary results showing specific decorporation agents for Sr(II) that do not bind Ca(II); Sr(II) is ...
SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health